ClinicalTrials.Veeva

Menu

Analysis of in Vitro Biological Reaction of Diaphragmatic Prothesis When Congenital Diaphragmatic Hernia (CDH) Repair

U

University Hospital, Strasbourg, France

Status

Completed

Conditions

Congenital Diaphragmatic Repair

Treatments

Procedure: Foreskin resection

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

In case of CDH, the incomplete development of a part of the diaphragm allows abdominal viscera to herniate into thorax cavity during fetal development and impaired lung and heart development.

After birth, CDH patients who survived thanks to an active reanimation management undergo diaphragmatic repair. In case of large defect, a patch is needed to complete diaphragmatic closure. Thanks to primary cell culture from foreskin, peritoneal epithelium or cremaster dedicated to incineration investigators want to analyse biological integration of actually used prothesis and others innovations.

Enrollment

1 patient

Sex

All

Ages

Under 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Minor aged 0 (day of birth) to 14 years
  • Patient for whom an indication of posthectomy and / or cure of inguinal hernia and / or testicular ectopy is retained
  • Patient whose legal representatives have agreed to the use of operational waste from mesenchymal tissues (foreskin, cremaster and peritoneum) destined for incineration.
  • Patient affiliated to a social security scheme

Exclusion criteria

  • parents don't agree to the use of its operating waste for research purposes

Trial contacts and locations

1

Loading...

Central trial contact

Isabelle TALON, MD; Anne SCHNEIDER, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems